Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Amgen: $3.33 million vs. $2.8 million
Simplified Text
Amgen lobbying spending was $3.33 million vs $2.8 million
Confidence Score
0.900
Claim Maker
Megan R. Wilson
Context Type
News Article
Context Details
{
    "date": "2024-04-24",
    "topic": "Pharmaceutical Lobbying",
    "company": "Amgen",
    "spending_2024": "$3.33 million",
    "spending_previous_year": "$2.8 million"
}
UUID
9fdb0107-bb4c-4396-8279-375f2d2dd47c
Vector Index
✗ No vector
Created
September 11, 2025 at 10:27 PM (22 hours ago)
Last Updated
September 11, 2025 at 10:27 PM (22 hours ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996
51 claims 🔥
22 hours ago
https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996

Pharmaceutical industry lobbying spending surged in Q1 2024. Increased spending focuses on PBM reform and other congressional issues. This follows recent government funding bill negotiations.

Pharmaceutical Industry
Lobbying
Healthcare Policy
Politics
Congress
PBM Reform

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP